Geyser Brands Inc. (TSX.V: GYSR) Generates First Revenues, Anticipates Receipt of Additional Health Canada Licenses
Geyser Brands’ first revenues of $79,434, generated during Q1 2019, represent a gross profit margin of 81 percent The company is nearing final TSX Venture Exchange conditional approval of its transaction to acquire Solace Management Group Inc. Geyser Brands subsidiary Apothecary Botanicals has received a standard processing license from Health Canada, which will allow the company to extend its CBD products to the regulated Canadian consumer medical market Geyser Brands Inc. (TSX.V: GYSR), a global science-led consumer health care company that builds and markets some of the world’s most loved cannabis products and brands, continues to achieve its stated strategic…